High-dose ionizing radiation regulates gene expression changes in the MCF7 breast cancer cell line

Anticancer Research

Volumn 35, Issue 5, 2015, Pages 2577-2592

  Bravatà, Valentina ^a   Minafra, Luigi ^a   Russo, Giorgio ^a   Forte, Giusi Irma ^a   Cammarata, Francesco P ^a   Ripamonti, Marilena ^a   Casarino, Carlo ^a   Augello, Giuseppa ^b   Costantini, Francesca ^b   Barbieri, Giovanna ^b   Messa, Cristina ^a,d,e   Gilardi, Maria C ^a,c,e  

^a Institute for Molecular Bioimaging and Physiology National Research Council (IBFM CNR LATO)   (Italy)

^b CNR   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Intraoperative electron radiation therapy; IOERT; Ionizing radiation; IR; MCF7 breast cancer cells; Microarray

Indexed keywords

ADAM METALLOPEPTIDASE WITH THROMBOSPONDIN TYPE 1 MOTIF 9; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CAVEOLIN 1; COMPLEMENTARY DNA; FAMILY WITH SEQUENCE SIMILARITY 49 MEMBER B; FLOTILLIN 1; GELATINASE B; HISTONE; HISTONE H2AX; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; LAMIN; LAMIN B1; LYMPHOID ENHANCER FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEAR RECEPTOR NR4A3; NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 1; PROTEIN; PROTEIN FOS; PROTEIN KINASE B; PROTEIN P21; SURVIVIN; THROMBOSPONDIN; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR JUNB; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL CYCLE REGULATION; CELL DEATH; CELL MEMBRANE; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CLONOGENESIS; CLONOGENIC ASSAY; COLONY FORMING UNIT; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DOWN REGULATION; ELECTRON THERAPY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INTRAOPERATIVE ELECTRON RADIATION THERAPY; INTRAOPERATIVE RADIOTHERAPY; IONIZING RADIATION; LIPID RAFT; MCF 7 CELL LINE; PHASE CONTRAST MICROSCOPY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIATION DOSE; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; WESTERN BLOTTING; BREAST NEOPLASMS; CELL AGING; DNA MICROARRAY; FEMALE; GENETICS; PATHOLOGY; RADIATION RESPONSE;

BREAST NEOPLASMS; CELL AGING; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIATION TOLERANCE; RADIATION, IONIZING;

EID: 84929673249     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Bernier J, Viale G, Orecchia R, Ballardini B, Richetti A, Bronz L, Franzetti-Pellanda A, Intra M and Veronesi U: Partial irradiation of the breast: Old challenges, new solutions. Breast 15: 466-75, 2006.
2. Offersen BV, Overgaard M, Kroman N and Overgaard J: Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol 90: 1-13, 2009.
3. Veronesi U, Orecchia R, Luini A, Galimberti V, Zurrida S, Intra M, Veronesi P, Arnone P, Leonardi MC, Ciocca M, Lazzari R, Caldarella P, Rotmensz N, Sangalli C, Sances D and Maisonneuve P: Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat 124: 141-51, 2010.
4. Kraus-Tiefenbacher U, Bauer L, Scheda A, Schoeber C, Schaefer J, Steil V and Wenz F: Intraoperative radiotherapy (IOERT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy. BMC Cancer 7: 178, 2007.
5. Wallner P, Arthur D, Bartelink H Connolly J, Edmundson G, Giuliano A, Goldstein N, Hevezi J, Julian T, Kuske R, Lichter A, McCormick B, Orecchia R, Pierce L, Powell S, Solin L, Vicini F, Whelan T, Wong J and Coleman CN, Workshop Participants: Workshop on partial breast irradiation: state of the art and the science. J Natl Cancer Inst 96: 175-184, 2004.
6. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, Julian TB, Marks LB, Todor DA, Vicini FA, Whelan TJ, White J, Wo JY and Harris JR: Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74: 987-1001, 2009.
7. Lomax ME, Folkes LK and O'Neill P: Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. Clin Oncol (R Coll Radiol) 25: 578-85, 2013.
8. Multhoff G and Radons J: Radiation, inflammation, and immune responses in cancer. Front Oncol 2: 58, 2012.
9. Eriksson D and Stigbrand T: Radiation-induced cell death mechanisms. Tumour Biol 31: 363-72, 2010.
10. Surova O and Zhivotovsky B: Various modes of cell death induced by DNA damage. Oncogene 32: 3789-97, 2013.
11. West CM and Barnett GC: Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med 3(8): 52, 2011.
12. Di Maggio FM, Minafra L, Forte GI, Cammarata FP, Lio D, Messa C, Gilardi MC and Bravatà V: Portrait of inflammatory response to ionizing radiation treatment. Journal of Inflammation 12: 14, 2015.
13. Golden EB, Pellicciotta I, Demaria S, Barcellos-Hoff MH and Formenti SC: The convergence of radiation and immunogenic cell death signaling pathways. Front Oncol 2: 88, 2012.
14. Xu QY, Gao Y, Liu Y, Yang WZ and Xu XY: Identification of differential gene expression profiles of radioresistant lung cancer cell line established by fractionated ionizing radiation in vitro. Chin Med J (Engl) 121: 1830-7, 2008.
15. Snyder AR, Morgan WF: Gene expression profiling after irradiation: clues to understanding acute and persistent responses? Cancer Metastasis Rev 23: 259-68, 2004
16. Bravatà V, Cammarata FP, Forte GI and Minafra L: "Omics" of HER2-positive breast cancer. OMICS 17: 119-29, 2013.
17. 18F-FDG uptake in breast cancer patients: a preliminary research. J Exp Clin Cancer Res 32: 23, 2013.
18. Minafra L, Norata R, Bravatà V, Viola M, Lupo C, Gelfi C and Messa C: Unmasking epithelial-mesenchymal transition in a breast cancer primary culture: a study report. BMC Res Notes 5: 343, 2012.
19. Minafra L, Bravatà V, Forte GI, Cammarata FP, Gilardi MC and Messa C: Gene expression profiling of epithelial-mesenchymal transition in primary breast cancer cell culture. Anticancer Res 34: 2173-83, 2014.
20. International Atomic Energy Agency: Adsorbed Dose Determination in External Beam Radiotherapy. An International Code of Practice for Dosimetry Based on Standards of Absorbed Dose to Water. Technical Reports Series No. 398, Vienna, 2000.
21. Russo G, Casarino C, Arnetta G, Candiano G, Stefano A, Alongi F, Borasi G, Messa C and Gilardi MC: Dose distribution changes with shielding disc misalignments and wrong orientations in breast IOERT: a Monte Carlo-GEANT4 and experimental study. J Appl Clin Med Phys 13: 3817, 2012.
22. Franken NAP, Rodermond HM, Stap J, Haveman J and van Bree C: Clonogenic assay of cells in vitro. Nature Protocols 1: 2315-2319, 2006.
23. Edgar R, Domrachev M and Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210, 2002.
24. Rozen S and Skaletsky HJ: Primer3 on the WWW for general users and for biologist programmers. In: Bioinformatics Methods and Protocols: Methods in Molecular Biology. Krawetz S and Misener S (eds.). Humana Press, Totowa, NJ: 365-386, 2000.
25. Primer3 tool. http//fokker.wi.mit.edu/primer3.
26. Xavier R, Brennan T, Li Q, McCormack C and Seed B: Membrane compartmentation is required for efficient T cell activation. Immunity 8: 723-732, 1998.
27. Panganiban RA, Snow AL and Day RM: Mechanisms of radiation toxicity in transformed and non-transformed cells. Int J Mol Sci 4: 15931-58, 2013.
28. Jan M van Deursen: The role of senescent cells in ageing. Nature 509: 439-446, 2014.
29. Becker KG, Hosack DA, Dennis G Jr, Lempicki RA, Bright TJ, Cheadle C and Engel J: PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics 4: 61,2003.
30. Lingwood D and Simons K: Lipid rafts as a membrane-organizing principle. Science 327: 46-50, 2010.
31. Barbieri G1, Rimini E and Costa MA: Effects of human leukocyte antigen (HLA)-DR engagement on melanoma cells. Int J Oncol 38(6): 1589-95, 2011.
32. Stuermer CA, Lang DM, Kirsch F, Wiechers M, Deininger SO and Plattner H: Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and -2. Mol Biol Cell 12: 3031-3045, 2001.
33. Dent P, Yacoub A, Fisher PB, Hagan MP and Grant S: MAPK pathways in radiation responses. Oncogene 22: 5885-96, 2003.
34. McBride WH, Iwamoto KS, Syljuasen R, Pervan M and Pajonk F: The role of the ubiquitin/proteasome system in cellular responses to radiation. Oncogene 22: 5755-73, 2003.
35. Aravindan S, Natarajan M, Ramraj SK, Pandian V, Khan FH, Herman TS and Aravindan N: Abscopal effect of low-LET γ-radiation mediated through Rel protein signal transduction in a mouse model of non targeted radiation response. Cancer Gene Ther 21: 54-9, 2014.
36. Chen X, Shen B, Xia L, Khaletzkiy A, Chu D, Wong JY and Li JJ: Activation of nuclear factor κB in radioresistance of TP53-inactive human keratinocytes. Cancer Res 62: 1213-21, 2002.
37. Starenki D, Namba H, Saenko V, Ohtsuru A and Yamashita S: Inhibition of nuclear factor-kappaB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells. J Clin Endocrinol Metab 89: 410-8, 2004.
38. Yamamoto Y and Gaynor RB: Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin Invest 107: 135-42, 2001.
39. Veeraraghavan J, Natarajan M, Aravindan S, Herman TS and Aravindan N: Radiation-triggered tumor necrosis factor (TNF)-α-NFκB cross-signaling favors survival advantage in human neuroblastoma cells. J Biol Chem 286: 21588-600, 2011.
40. Aravindan S, Natarajan M, Awasthi V, Herman TS and Aravindan N: Novel synthetic monoketone transmute radiation-triggered NFκB-dependent TNFα cross-signaling feedback maintained NFκB and favors neuroblastoma regression. PLoS One 8(8): e72464, 2013.
41. Zhou H, Gao J, Lu ZY, Lu L, Dai W and Xu M: Role of c-Fos/JunD in protecting stress-induced cell death. Cell Prolif 40: 431-44, 2007.
42. Benkoussa M, Brand C, Delmotte MH, Formstecher P and Lefebvre P: Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol Cell Biol 22: 4522-34, 2002.
43. Kajanne R, Miettinen P, Tenhunen M, Leppä S: Transcription factor AP1 promotes growth and radioresistance in prostate cancer cells. Int J Oncol 35: 1175-82, 2009.
44. Chiang PC, Chou RH, Chien HF, Tsai T and Chen CT: Chloride intracellular channel 4 involves in the reduced invasiveness of cancer cells treated by photodynamic therapy. Lasers Surg Med 45: 38-47, 2013.
45. Speake WJ, Dean RA, Kumar A, Morris TM, Scholefield JH and Watson SA: Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion. Eur J Surg Oncol 31: 869-74, 2005.
46. Che J, Zhang FZ, Zhao CQ, Hu XD and Fan SJ: Cyclopamine is a novel Hedgehog signaling inhibitor with significant antiproliferative, anti-invasive and anti-estrogenic potency in human breast cancer cells. Oncol Lett 5(4): 1417-1421, 2013.
47. Sun M, Guo X, Qian X, Wang H, Yang C, Brinkman KL, Serrano-Gonzalez M, Jope RS, Zhou B, Engler DA, Zhan M, Wong ST, Fu L and Xu B.: Activation of the ATM-SNAIL pathway promotes breast cancer metastasis. J Mol Cell Biol 4: 304-15, 2012.
48. Yang G, Zhang G Pittelkow MR, Ramoni M and Tsao H: Expression profiling of UVB response in melanocytes identifies a set of p53-target genes. J Invest Dermatol 126: 2490-506, 2006.
49. Sood R, Ritov G, Richter-Levin G and Barki-Harrington L: Selective increase in the association of the β2 adrenergic receptor, β Arrestin-1 and p53 with Mdm2 in the ventral hippocampus one month after underwater trauma. Behav Brain Res 240: 26-8, 2013.
50. Freund A, Laberge RM, Demaria M and Campisi J: Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell 23: 2066-75, 2012.
51. Damaraju S, Murray D, Dufour J, Carandang D, Myrehaug S, Fallone G, Field C, Greiner R, Hanson J and Cass CE, Parliament M: Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res 12: 2545-54, 2006.
52. Pan D, Kocherginsky M and Conzen SD: Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res 71: 6360-70, 2011.
53. O'Neill F, Madden SF, Aherne ST, Clynes M, Crown J, Doolan P and O'Connor R: Gene expression changes as markers of early lapatinib response in a panel of breast cancer cell lines. Mol Cancer 11: 41, 2012.
54. Patani N, Martin LA, Reis-Filho JS and Dowsett M: The role of caveolin-1 in human breast cancer. Breast Cancer Res Treat 131: 1-15, 2012.
55. Hehlgans S and Cordes N: Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance. Am J Cancer Res 1: 521-30, 2011.
56. Hayashi K, Matsuda S, Machida K, Yamamoto T, Fukuda Y, Nimura Y, Hayakawa T and Hamaguchi M: Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res 61: 2361-4, 2001.
57. Bionda C, Hadchity E, Alphonse G, Chapet O, Rousson R, Rodriguez-Lafrasse C and Ardail D: Radioresistance of human carcinoma cells is correlated to a defect in raft membrane clustering. Free Radic Biol Med 43: 681-6942007.
58. Rotolo J, Stancevic B, Zhang J, Hua G, Fuller J, Yin X, Haimovitz-Friedman A, Kim K, Qian M, Cardó-Vila M, Fuks Z, Pasqualini R, Arap W and Kolesnick R: Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice. J Clin Invest 122: 1786-1790, 2012.
59. Su C, Gao G, Schneider S, Helt C, Weiss C, O'Reilly MA, Bohmann D and Zhao J: DNA damage induces down regulation of histone gene expression through the G1 checkpoint pathway. EMBO J 23: 1133-43, 2004.
60. Meador JA, Ghandhi SA and Amundson SA: p53-independent down-regulation of histone gene expression in human cell lines by high- and low-LET radiation. Radiat Res 175: 689-99, 2011.
61. Bird AW, Yu DY, Pray-Grant MG, Qiu Q, Harmon KE, Megee PC, Grant PA, Smith MM and Christman MF: Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair. Nature 419: 411-5, 2002.
62. Du YC, Gu S, Zhou J, Wang T, Cai H, Macinnes MA, Bradbury EM and Chen X: The dynamic alterations of H2AX complex during DNA repair detected by a proteomic approach reveal the critical roles of Ca(2+)/calmodulin in the ionizing radiationinduced cell cycle arrest. Mol Cell Proteomics 5: 1033-44, 2006.
63. 2+ from endoplasmic reticulum to mitochondria plays a positive role in the early stage of UV- or TNFα-induced apoptosis. Biochem Biophys Res Commun 373: 42-7, 2008.
64. Fu NY, Sukumaran SK and Yu VC: Inhibition of ubiquitin-mediated degradation of MOAP1 by apoptotic stimuli promotes BAX function in mitochondria. Proc Natl Acad Sci USA 104: 10051-6, 2007.
65. Kim MJ1, Lee KH and Lee SJ. Ionizing radiation utilizes c-JUN N-terminal kinase for amplification of mitochondrial apoptotic cell death in human cervical cancer cells. FEBS J 275: 2096-108, 2008.
66. Sheard MA: Ionizing radiation as a response enhancing agent for CD95-mediated apoptosis. Int J Cancer 96: 213-220, 2001.
67. Fulda S, Scaffidi C, Pietsch T, Krammer PH, Peter ME and Debatin KM: Activation of the CD95 (APO1/ FAS) pathway in drug- and gamma-irradiation induced apoptosis of brain tumor cells. Cell Death Differ 10: 884-893, 1998.
68. Lin J, Yang Q, Wilder PT, Carrier F and Weber DJ: The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma. J Biol Chem 285: 27487-98, 2010.
69. Mao XW, Green LM, Mekonnen T, Lindsey N and Gridley DS: Gene expression analysis of oxidative stress and apoptosis in proton-irradiated rat retina. In Vivo 24: 425-30, 2010.
70. Harris PS, Venkataraman S, Alimova I, Harris PS, Venkataraman S and Alimova I: Polo-like kinase 1 (PLK1) inhibition suppresses cell growth and enhances radiation sensitivity in medulloblastoma cells. BMC Cancer 12: 80, 2012.
71. Yasuda S, Oceguera-Yanez F, Kato T, Yasuda S, Oceguera-Yanez F and Kato T: Cdc42 and mDia3 regulate microtubule attachment to kinetochores. Nature 428: 767-71, 2004.
72. Lee G, Origanti S, White LS, Lee G, Origanti S and White LS: Contributions made by CDC25 phosphatases to proliferation of intestinal epithelial stem and progenitor cells. Plos One 6: e15561, 2011.
73. Boutros R, Lobjois V and Ducommun B. CDC25 phosphatases in cancer cells: Key players? Good targets? Nat Rev Cancer 7: 495-507, 2007.
74. Ray D and Kiyokawa H. CDC25A phosphatase: a rate-limiting oncogene that determines genomic stability. Cancer Res 68: 1251-3, 2008.
75. Zhao Y, Cui Y, Han J, Zhao Y, Cui Y and Han J: Cell division cycle 25 homolog c effects on low-dose hyperradiosensitivity and induced radioresistance at elevated dosage in A549 cells. J Radiat Res 53: 686-94, 2012.
76. Li J, Yang CX, Mei ZJ, Li J, Yang CX and Mei ZJ: Involvement of CDC25C in cell-cycle alteration of a radioresistant lung cancer cell line established with fractionated ionizing radiation. Asian Pac J Cancer Prev 14: 5725-30, 2013.
77. Minafra L and Bravatà V: Cell and molecular response to IOERT treatment. Transl Cancer Res 3: 32-47, 2014.